The problem for the lab-leak position is that the U.S. has never had access to the Wuhan lab and has thus been unable to ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results